1-16 of 16
Gerard Socié
Close
Sort by
Journal Articles

Haploidentical stem cell donor choice for patients with acute myeloid leukemia: a study from the ALWP of the EBMT

Clinical Trials & Observations
Jaime Sanz, Myriam Labopin, Didier Blaise, Anna Maria Raiola, Alessandro Busca, Jan Vydra, Johanna Tischer, Patrice Chevallier, Stefania Bramanti, Renato Fanin, Gérard Socié, Edouard Forcade, Nicolaus Kröger, Yener Koc, Maija Itäla-Remes, Marco Zecca, Arnon Nagler, Eolia Brissot, Alexandros Spyridonidis, Ali Bazarbachi, Sebastian Giebel, Simona Piemontese, Mohamad Mohty, Fabio Ciceri
Journal: Blood Advances
Blood Adv (2024) 8 (10): 2332–2341.
https://doi.org/10.1182/bloodadvances.2023012133
Published: 2024
Journal Articles

Chronic GvHD NIH Consensus Project Biology Task Force: evolving path to personalized treatment of chronic GvHD

Nataliya P. Buxbaum, Gerard Socié, Geoffrey R. Hill, Kelli P. A. MacDonald, Victor Tkachev, Takanori Teshima, Stephanie J. Lee, Jerome Ritz, Stefanie Sarantopoulos, Leo Luznik, Defu Zeng, Sophie Paczesny, Paul J. Martin, Steven Z. Pavletic, Kirk R. Schultz, Bruce R. Blazar
Journal: Blood Advances
Blood Adv (2023) 7 (17): 4886–4902.
https://doi.org/10.1182/bloodadvances.2022007611
Published: 2023
Journal Articles

Comorbidities in transplant recipients with acute myeloid leukemia receiving low-intensity conditioning regimens: an ALWP EBMT study

Joshua A. Fein, Roni Shouval, Jacques-Emmanuel Galimard, Myriam Labopin, Gérard Socié, Jürgen Finke, Jan J. Cornelissen, Ram Malladi, Maija Itälä-Remes, Patrice Chevallier, Kim H. Orchard, Donald Bunjes, Mahmoud Aljurf, Marie Thérèse Rubio, Jurjen Versluis, Mohamad Mohty, Arnon Nagler
Journal: Blood Advances
Blood Adv (2023) 7 (10): 2143–2152.
https://doi.org/10.1182/bloodadvances.2022008656
Published: 2023
Includes: Supplemental data
Journal Articles

Prospective external validation of biomarkers to predict acute graft-versus-host disease severity

Clinical Trials & Observations
Marie Robin, Raphael Porcher, David Michonneau, Laetitia Taurines, Flore Sicre de Fontbrune, Aliénor Xhaard, Bastien Oriano, Aurélien Sutra Del Galy, Régis Peffault de Latour, Gérard Socié, Marie-Hélène Schlageter
Journal: Blood Advances
Blood Adv (2022) 6 (16): 4763–4772.
https://doi.org/10.1182/bloodadvances.2022007477
Published: 2022
Includes: Supplemental data
Journal Articles

RNA sequencing of chronic GVHD skin lesions defines shared and unique inflammatory pathways characterizing lichen planus and morphea

Clinical Trials & Observations
Habib Zouali, Juliette Lemasson, Andreea Calugareanu, Christophe Battail, David Michonneau, Hélène le Buanec, Chloé Grolleau, Charles Cassius, Marie Robin, Marine Merandet, Gabor Dobos, Thibault Mahevas, Michel Rybojad, Adèle de Masson, Reyhan Amode, Anne Boland, Laurence Michel, Flore Sicre de Fontbrune, Régis Peffault de Latour, Patrick Bruneval, Hafid Ait-Oufella, Maxime Battistella, Marie Jachiet, Martine Bagot, Jean-François Deleuze, Gérard Socié, Jean-David Bouaziz
Journal: Blood Advances
Blood Adv (2022) 6 (9): 2805–2811.
https://doi.org/10.1182/bloodadvances.2021004707
Published: 2022
Includes: Supplemental data
Journal Articles

Genomic analysis of primary and secondary myelofibrosis redefines the prognostic impact of ASXL1 mutations: a FIM study

Clinical Trials & Observations
Damien Luque Paz, Jérémie Riou, Emmanuelle Verger, Bruno Cassinat, Aurélie Chauveau, Jean-Christophe Ianotto, Brigitte Dupriez, Françoise Boyer, Maxime Renard, Olivier Mansier, Anne Murati, Jérôme Rey, Gabriel Etienne, Véronique Mansat-De Mas, Suzanne Tavitian, Olivier Nibourel, Stéphane Girault, Yannick Le Bris, François Girodon, Dana Ranta, Jean-Claude Chomel, Pascale Cony-Makhoul, Pierre Sujobert, Margot Robles, Raouf Ben Abdelali, Olivier Kosmider, Laurane Cottin, Lydia Roy, Ivan Sloma, Fabienne Vacheret, Mathieu Wemeau, Pascal Mossuz, Borhane Slama, Vincent Cussac, Guillaume Denis, Anouk Walter-Petrich, Barbara Burroni, Nathalie Jézéquel, Stéphane Giraudier, Eric Lippert, Gérard Socié, Jean-Jacques Kiladjian, Valérie Ugo
Journal: Blood Advances
Blood Adv (2021) 5 (5): 1442–1451.
https://doi.org/10.1182/bloodadvances.2020003444
Published: 2021
Includes: Supplemental data
Journal Articles

Cellular and molecular profiling of T-cell subsets at the onset of human acute GVHD

Eleonora Latis, David Michonneau, Claire Leloup, Hugo Varet, Régis Peffault de Latour, CRYOSTEM Consortium, Elisabetta Bianchi, Gérard Socié, Lars Rogge
Journal: Blood Advances
Blood Adv (2020) 4 (16): 3927–3942.
https://doi.org/10.1182/bloodadvances.2019001032
Published: 2020
Includes: Supplemental data
Journal Articles

The development of ruxolitinib for glucocorticoid-refractory acute graft-versus-host disease

Clinical Trials & Observations
Robert Zeiser, Gérard Socié
Journal: Blood Advances
Blood Adv (2020) 4 (15): 3789–3794.
https://doi.org/10.1182/bloodadvances.2020002097
Published: 2020
Journal Articles

Comparing transplant outcomes in ALL patients after haploidentical with PTCy or matched unrelated donor transplantation

Clinical Trials & Observations
Monzr M. Al Malki, Dongyun Yang, Myriam Labopin, Boris Afanasyev, Emanuele Angelucci, Asad Bashey, Gérard Socié, Amado Karduss-Urueta, Grzegorz Helbig, Martin Bornhauser, Riitta Niittyvuopio, Arnold Ganser, Fabio Ciceri, Arne Brecht, Yener Koc, Nelli Bejanyan, Francesca Ferraro, Partow Kebriaei, Sally Mokhtari, Armin Ghobadi, Ryotaro Nakamura, Stephen J. Forman, Richard Champlin, Mohamad Mohty, Stefan O. Ciurea, Arnon Nagler
Journal: Blood Advances
Blood Adv (2020) 4 (9): 2073–2083.
https://doi.org/10.1182/bloodadvances.2020001499
Published: 2020
Includes: Supplemental data
Journal Articles

Functional and phylogenetic alterations in gut microbiome are linked to graft-versus-host disease severity

Mathilde Payen, Ioannis Nicolis, Marie Robin, David Michonneau, Johanne Delannoye, Camille Mayeur, Nathalie Kapel, Béatrice Berçot, Marie-José Butel, Jérôme Le Goff, Gérard Socié, Clotilde Rousseau
Journal: Blood Advances
Blood Adv (2020) 4 (9): 1824–1832.
https://doi.org/10.1182/bloodadvances.2020001531
Published: 2020
Includes: Supplemental data
Journal Articles

Allogeneic reactivity–mediated endothelial cell complications after HSCT: a plea for consensual definitions

Simona Pagliuca, David Michonneau, Flore Sicre de Fontbrune, Aurélien Sutra del Galy, Aliénor Xhaard, Marie Robin, Régis Peffault de Latour, Gérard Socie
Journal: Blood Advances
Blood Adv (2019) 3 (15): 2424–2435.
https://doi.org/10.1182/bloodadvances.2019000143
Published: 2019
Journal Articles

Randomized controlled study of ECP with methoxsalen as first-line treatment of patients with moderate to severe cGVHD

Clinical Trials & Observations
Madan Jagasia, Christof Scheid, Gérard Socié, Francis Ayuketang Ayuk, Johanna Tischer, Michele L. Donato, Árpád Bátai, Heidi Chen, Sheau-Chiann Chen, Thomas Chin, Henri Boodée, Ghaith Mitri, Hildegard T. Greinix
Journal: Blood Advances
Blood Adv (2019) 3 (14): 2218–2229.
https://doi.org/10.1182/bloodadvances.2019000145
Published: 2019
Includes: Supplemental data
Journal Articles

Long-term follow-up of a phase 3 clinical trial of inolimomab for the treatment of primary steroid refractory aGVHD

Clinical Trials & Observations
Gérard Socié, Noel Milpied, Ibrahim Yakoub-Agha, Jacques-Olivier Bay, Sabine Fürst, Karin Bilger, Felipe Suarez, Mauricette Michallet, Philippe Lewalle, David Liens, Catherine Mathis, Eric Guemas, Jean-Paul Vernant
Journal: Blood Advances
Blood Adv (2019) 3 (2): 184–186.
https://doi.org/10.1182/bloodadvances.2018028282
Published: 2019
Journal Articles

Related donor transplants: has posttransplantation cyclophosphamide nullified the detrimental effect of HLA mismatch?

Clinical Trials & Observations
Tara M. Robinson, Ephraim J. Fuchs, Mei-Jie Zhang, Andrew St. Martin, Myriam Labopin, Daniel A. Keesler, Didier Blaise, Asad Bashey, Jean-Henri Bourhis, Fabio Ciceri, Stefan O. Ciurea, Steven M. Devine, Mohamad Mohty, Shannon R. McCurdy, Noel Milpied, Ian K. McNiece, Vanderson Rocha, Rizwan Romee, Gerard Socie, Ibrahim Yakoub-Agha, Robert J. Soiffer, Mary Eapen, Arnon Nagler
Journal: Blood Advances
Blood Adv (2018) 2 (11): 1180–1186.
https://doi.org/10.1182/bloodadvances.2018018291
Published: 2018
Journal Articles

Clinical profile, biological markers, and comorbidity index as predictors of transplant-related mortality after allo-HSCT

Clinical Trials & Observations
Aliénor Xhaard, Renato Cunha, Marc Busson, Marie Robin, Nathalie Dhedin, Tereza Coman, Aurélie Cabannes-Hamy, Flore Sicre de Fontbrune, David Michonneau, Gérard Socié, Rodrigo T. Calado, Régis Peffault de Latour
Journal: Blood Advances
Blood Adv (2017) 1 (18): 1409–1413.
https://doi.org/10.1182/bloodadvances.2017008094
Published: 2017
Journal Articles

Alternative donors for allogeneic hematopoietic stem cell transplantation in poor-risk AML in CR1

Jurjen Versluis, Myriam Labopin, Annalisa Ruggeri, Gerard Socie, Depei Wu, Liisa Volin, Didier Blaise, Noel Milpied, Charles Craddock, Ibrahim Yakoub-Agha, Johan Maertens, Per Ljungman, Anne Huynh, Mauricette Michallet, Eric Deconinck, Patrice Chevallier, Jakob Passweg, Fabio Ciceri, Mohamad Mohty, Jan J. Cornelissen, Arnon Nagler
Journal: Blood Advances
Blood Adv (2017) 1 (7): 477–485.
https://doi.org/10.1182/bloodadvances.2016002386
Published: 2017
Includes: Supplemental data